Selpercatinib plus cemiplimab in RET positive medullary thyroid cancer patient with skin cancers.
Saved in:
| Title: | Selpercatinib plus cemiplimab in RET positive medullary thyroid cancer patient with skin cancers. |
|---|---|
| Authors: | Locati LD; Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.; Medical Oncology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Puce F; Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.; Medical Oncology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Amoroso V; Medical Oncology Unit, ASST Spedali Civili of Brescia, Brescia, Italy., Sottotetti F; Medical Oncology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Berruti A; Medical Oncology Unit, ASST Spedali Civili of Brescia, Brescia, Italy.; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy. |
| Source: | Tumori [Tumori] 2025 Dec; Vol. 111 (6), pp. NP12-NP15. Date of Electronic Publication: 2025 Nov 09. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 0111356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2038-2529 (Electronic) Linking ISSN: 03008916 NLM ISO Abbreviation: Tumori Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
